T1	intervention 38 50	hypnotherapy
T2	control 58 68	gabapentin
T3	total-participants 472 474	15
T4	eligibility 475 601	women with a personal history of breast cancer or an increased risk of breast cancer who reported at least one daily hot flash
T8	total-participants 911 913	27
T9	total-participants 940 942	15
T10	control-participants 1003 1004	8
T11	intervention-participants 1019 1020	7
T13	cv-cont-median 1092 1095	4.5
T14	iv-cont-median 1122 1123	5
T15	outcome 1149 1160	HFSS scores
T16	cv-cont-median 1166 1169	7.5
T17	iv-cont-median 1196 1198	10
T12	outcome 1040 1087	median number of daily hot flashes at enrolment
T18	outcome 1243 1277	median number of daily hot flashes
T19	outcome 1361 1372	median HFSS
T5	condition 90 101	hot flashes
T7	outcome-Measure 858 909	Hot Flash Related Daily Interference Scale (HFRDIS)
T20	outcome 1452 1474	HFRDIS scores improved
T21	outcome 1224 1237	After 8 weeks
T22	cv-cont-median 1293 1298	33.3%
T23	iv-cont-median 1328 1331	80%
T24	cv-cont-median 1388 1393	33.3%
T25	iv-cont-median 1423 1426	85%
T26	cv-cont-mean 1478 1483	51.6%
T27	iv-cont-median 1515 1520	55.2%
T6	outcome-Measure 762 789	number of daily hot flashes
T28	outcome-Measure 794 825	hot flash severity score (HFSS)
